NEW YORK (AP) — Shares of companies that are studying potential vaccines for Ebola are climbing in aftermarket trading after federal officials announced that the first case of the disease has been diagnosed in the U.S. The Centers for Disease Control says a patient being treated at a hospital in Dallas tested positive for the disease.